Phentermine is still one of the best-known prescription appetite suppressants, but it is no longer the only serious option. For many people, the most effective choices now are not stimulants at all. Newer prescription weight loss medications can reduce hunger, quiet “food noise,” improve fullness after meals, and make long-term maintenance more realistic than relying on willpower alone.
The best alternative depends on what is actually driving your overeating. Constant physical hunger, strong cravings, night snacking, binge-type eating, medication side effects, blood sugar issues, and insurance limits all point toward different choices. The most useful way to compare these drugs is not by hype, but by how much weight they typically help people lose, how they work, what side effects matter most, and who they tend to fit best.
Table of Contents
- What appetite suppressants mean now
- Best prescription options beyond phentermine
- Which medication fits best
- Side effects and safety tradeoffs
- Using medication for plateaus and maintenance
- Questions to ask your clinician
What appetite suppressants mean now
The phrase “appetite suppressant” used to mean a stimulant that helped you feel less hungry for a while. That is no longer a very complete definition. Today, prescription weight loss drugs reduce eating in several different ways:
- lowering baseline hunger
- increasing fullness after smaller meals
- slowing stomach emptying
- reducing reward-driven cravings
- making it easier to stop eating once you start
- helping people stick to a calorie deficit with less mental friction
That matters because not everyone overeats for the same reason. Some people are physically hungry all day. Others do fairly well until the evening, then lose control around snacks, takeout, or sweets. Some struggle more with “food noise” than stomach hunger. A medication that works well for one pattern can feel mediocre for another.
This is also why newer options are often better described as anti-obesity medications rather than simple appetite suppressants. They are meant to support chronic weight management, not just provide a short-lived reduction in hunger. In other words, the goal is not to white-knuckle smaller portions for a few weeks. The goal is to make better intake sustainable for months and years.
That shift is one reason many people look beyond phentermine. Some want to avoid stimulant effects such as feeling keyed up, having trouble sleeping, or noticing a faster heart rate. Others want a medication that feels less like “forced appetite shutdown” and more like improved satiety and better control around food. If you want a broader overview of how the full medication landscape compares, weight loss medications explained is a useful next step, and people specifically comparing older stimulant choices with newer ones often start with phentermine safety and alternatives.
One more practical point: not every prescription option beyond phentermine is truly an appetite suppressant. Orlistat, for example, works mainly by reducing fat absorption, not by directly changing hunger. It still belongs in the conversation because it can help some people maintain a lower intake, but it behaves very differently from the incretin-based drugs and craving-focused medications.
Best prescription options beyond phentermine
For most adults who want a prescription alternative to phentermine, the main options are tirzepatide, semaglutide, liraglutide, naltrexone-bupropion, and orlistat. A sixth medication, setmelanotide, is highly specialized for rare genetic or hypothalamic forms of obesity and is not a routine option for general weight loss.
| Medication | How it helps | Approximate average weight loss in trials | Who it often fits best | Main drawbacks |
|---|---|---|---|---|
| Tirzepatide | Strong appetite reduction, earlier fullness, less food noise | About 15 to 21 percent | People prioritizing the strongest average results | GI side effects, injection, access and cost, thyroid warning |
| Semaglutide 2.4 mg | Strong satiety effect, smaller portions feel easier | About 15 percent | People wanting high efficacy with weekly dosing | GI side effects, injection, access and cost, thyroid warning |
| Liraglutide 3 mg | Improves fullness and reduces hunger | About 5 to 8 percent | People who cannot use or get weekly incretin options | Daily injection, GI side effects, lower average efficacy |
| Naltrexone-bupropion ER | Targets cravings, reward eating, and urge-driven snacking | About 5 to 9 percent | People with strong cravings or hedonic eating patterns | Nausea, insomnia, blood pressure concerns, seizure risk, no opioids |
| Orlistat | Reduces fat absorption rather than directly suppressing appetite | About 3 to 5 percent beyond lifestyle changes | People wanting a non-stimulant oral option | Oily stools, urgency, vitamin issues, low-fat diet needed |
| Setmelanotide | Targets the melanocortin pathway in selected genetic cases | Can be substantial in the right condition | Rare monogenic or syndromic obesity only | Not a routine option for common obesity |
These numbers are useful, but they are not a promise, and they are not perfectly apples-to-apples. Trial populations, treatment length, titration schedules, and dropout rates differ. Even so, the overall ranking is fairly clear.
Tirzepatide and semaglutide are currently the strongest mainstream options for appetite reduction and average weight loss. They tend to work best when the biggest problem is persistent hunger, large portions, grazing, or intrusive food thoughts. This is the class many people mean when they say they want something “better than phentermine.” A fuller look at this category is in GLP-1 medications for weight loss.
Liraglutide still has a role, but it is usually not the first pick when semaglutide or tirzepatide are available and affordable. Its daily injection schedule and lower average weight loss make it harder to justify unless access, coverage, or tolerability point that way.
Naltrexone-bupropion is different. It often makes more sense when overeating feels reward-driven rather than purely hunger-driven. Someone who says, “I am not starving, but I cannot stop thinking about chips, sweets, or late-night snacks,” may be describing a better fit for this medication than for an incretin drug. For a deeper medication-specific breakdown, see Contrave and how it works.
Orlistat is older, less glamorous, and usually weaker, but it still has a place. It may appeal to people who want a prescription pill, want to avoid stimulants, or cannot use the newer medications. It also tends to work best in people willing to keep dietary fat fairly moderate, because high-fat meals make the side effects much more obvious.
One additional option worth mentioning is topiramate alone. It is not FDA-approved as a standalone obesity drug, but some clinicians use it off-label when appetite, binge-type eating, or migraine prevention overlap. It can be effective, but it is not usually the cleanest first choice because of cognitive side effects and pregnancy concerns.
Which medication fits best
The smartest way to choose a prescription appetite suppressant is to match the medication to the eating pattern, medical history, and long-term plan.
When the best fit is usually tirzepatide or semaglutide
These are often the strongest picks when the main problem is genuine hunger, large meal size, constant thoughts about food, or repeated difficulty staying in a calorie deficit even with a solid routine. They are also commonly favored when a person has obesity plus cardiometabolic risk factors such as prediabetes, type 2 diabetes, sleep apnea, or fatty liver concerns.
In real life, these medications tend to be especially helpful for people who say things like:
- “I am hungry again too soon after eating.”
- “I can eat a normal meal and still want more.”
- “My appetite fights me every day.”
- “I need something strong enough to help me keep the weight off after I lose it.”
If you want a medication-specific deep dive on the highest-efficacy option, tirzepatide for weight loss is the most relevant follow-up.
When liraglutide can still make sense
Liraglutide is less potent on average, but it can still be useful when weekly options are not covered, when the clinician prefers a daily titration pattern, or when someone has already done reasonably well with that pathway before. It is not outdated so much as outperformed.
When naltrexone-bupropion may fit better than an incretin drug
This medication often makes more sense when the core problem is cravings, compulsive snacking, stress eating, or reward-driven eating. It may also appeal to people who strongly prefer pills over injections. A helpful way to think about it is this: incretin drugs often feel better for hunger and fullness, while naltrexone-bupropion can feel better for urge and craving control.
That distinction is practical. A person who struggles most with nighttime “I just want something” eating may respond differently than someone who is physically hungry at 10 a.m., 1 p.m., 4 p.m., and 9 p.m.
When orlistat deserves consideration
Orlistat fits best for people who want a non-stimulant oral option and are realistic about what it can and cannot do. It is usually not the “best” medication if the goal is maximal appetite suppression. It can be reasonable if cost matters, injections are a hard no, and the person is comfortable following a lower-fat eating pattern.
When the answer may be nutrition support, not just a stronger drug
Medication works better when meals are built to match the mechanism. People on satiety-focused drugs often do especially well when they center protein, fiber, and simple meal structure instead of trying to “eat as little as possible.” That is why many clinicians pair these prescriptions with a basic food plan rather than vague advice to eat less. For example, meal planning on GLP-1 medications is often more useful than chasing an even higher dose without fixing intake quality.
Side effects and safety tradeoffs
The strongest medication is not automatically the best medication. Side effects, contraindications, other prescriptions, and future plans can quickly change the answer.
Incretin-based medications
Tirzepatide, semaglutide, and liraglutide most often cause nausea, vomiting, diarrhea, constipation, burping, reflux, or early fullness that can tip into discomfort. These effects are often worst during dose escalation and often improve when people slow down meals, avoid greasy portions, stay hydrated, and do not force large meals through the medication.
Important tradeoffs include:
- personal or family history of medullary thyroid carcinoma or MEN 2
- prior pancreatitis or gallbladder issues that need individualized discussion
- severe gastrointestinal symptoms or suspected gastroparesis
- pregnancy or plans to conceive
- possible interaction issues with oral medications because gastric emptying slows
This is also the class where injections dominate the market, which matters for people deciding between convenience, comfort, and coverage. If you are trying to decide whether the tradeoff is worth it, weight loss pills vs injections is a helpful comparison.
Naltrexone-bupropion
This drug can be a strong option for cravings, but it has its own safety profile. Nausea, constipation, headache, dry mouth, dizziness, and insomnia are common early complaints. It also deserves caution or avoidance in people with uncontrolled high blood pressure, a seizure history, bulimia or anorexia nervosa, chronic opioid use, or recent MAOI use.
That opioid issue matters more than many people realize. Because naltrexone blocks opioid receptors, it can interfere with opioid pain medications and can precipitate withdrawal in the wrong setting. That makes medication review essential before starting it.
Orlistat
Orlistat’s side effects are mostly gastrointestinal and closely tied to dietary fat intake. Oily spotting, urgent stools, gas with discharge, and loose bowel movements are not rare. People who do well with it usually understand the rule quickly: the higher the fat load in a meal, the more unpleasant the feedback. A fat-soluble vitamin supplement is usually recommended because absorption of vitamins A, D, E, and K can be reduced.
Topiramate and other off-label options
Off-label does not mean wrong, but it does mean you should be more careful about why it is being used and what the backup plan is. Topiramate can reduce appetite and help some people, but tingling, taste changes, brain fog, and word-finding trouble are common enough that it is not an easy recommendation for everyone. Pregnancy risk also makes it a higher-stakes conversation.
Across all categories, the basic rule is simple: do not choose purely by average weight loss. Choose by the balance of effectiveness, tolerability, safety, and whether you can realistically stay on the treatment long enough for it to matter.
Using medication for plateaus and maintenance
This is where people often make the wrong comparison. They ask, “Which appetite suppressant helps me lose the most weight fast?” A better question is, “Which option helps me keep progressing when weight loss slows and then helps me hold the result?”
A true plateau is not always medication failure. Sometimes the issue is:
- incomplete dose titration
- lower daily movement as body weight drops
- calorie creep from weekends, liquid calories, or restaurant meals
- not enough protein or fiber, so hunger breaks through later
- constipation or fluid shifts masking fat loss on the scale
- stopping the behaviors that made the medication work in the first place
That is one reason the “best” drug can change over time. A medication that was enough to get the first 20 pounds off may feel less impressive near goal weight, when deficits are smaller and hunger biology pushes back harder.
In practice, there are a few sensible plateau strategies. First, check whether the current medication is actually being used at an effective maintenance dose and for long enough to judge it fairly. Second, identify whether the problem is still hunger or whether it has become habit drift, alcohol, snacking, or reduced activity. Third, match the next move to the real failure point. Someone whose appetite is still high may need a different satiety-focused drug. Someone whose appetite is mostly controlled but who still gets pulled into reward eating might do better with a different mechanism.
This is also where expectations need to be realistic. Many people regain weight after stopping anti-obesity medication, especially if appetite returns faster than structure and habits can compensate. That is why long-term planning matters. If the question is what to do when progress fades, what to do when weight loss medication stops working covers the common next steps. If the concern is what happens after reaching goal, weight loss maintenance after medication is the more relevant conversation.
The most durable results usually come from treating medication as one piece of a maintenance system: adequate protein, resistance training, enough daily movement, a few repeatable meals, and clear action triggers if regain starts. The medication helps manage biology. The routine keeps small slips from turning into a full rebound.
Questions to ask your clinician
The best office visit is not the one where you ask for the strongest drug by name. It is the one where you help your clinician match the medication to your real pattern.
Bring questions like these:
- Is my main issue physical hunger, cravings, binge-type eating, or loss of control at certain times of day?
- Which medication is most likely to fit my medical history, blood pressure, mental health history, and current prescriptions?
- Am I a better candidate for a pill or an injection?
- What amount of weight loss is realistic for this specific option over 3, 6, and 12 months?
- What side effects should make me call sooner rather than later?
- How will we know whether it is working enough to continue?
- What is the plan if insurance denies coverage or the medication becomes hard to get?
- If I eventually want to come off treatment, how do we reduce the risk of regain?
It also helps to discuss life stage and planning. Pregnancy plans, chronic pain treatment, sleep problems, GI issues, and other medications can all change the safest choice. For people who have not had that broader medical review yet, talking to a doctor before starting weight loss treatment is often a smart step.
The bottom line is that the best prescription appetite suppressant beyond phentermine is usually the one that targets your actual eating pattern and that you can tolerate, afford, and stay on long enough to matter. Right now, tirzepatide and semaglutide lead on average efficacy, naltrexone-bupropion remains useful for cravings and reward eating, orlistat still has a niche for oral non-stimulant treatment, and specialized cases may call for something entirely different.
References
- Pharmacologic Treatment of Overweight and Obesity in Adults 2024 (Review)
- Pharmacotherapy for obesity management in adults 2025 (Guideline)
- Once-Weekly Semaglutide in Adults with Overweight or Obesity 2021 (RCT)
- Tirzepatide Once Weekly for the Treatment of Obesity 2022 (RCT)
- A Guideline-Directed Approach to Obesity Treatment 2024 (Review)
Disclaimer
This article is for general educational purposes only and is not medical advice. Prescription weight loss medications have important contraindications, side effects, and drug interactions, so the right choice should be made with a qualified clinician who knows your health history and current medications.
If this article helped you, consider sharing it on Facebook, X (formerly Twitter), or any platform your audience uses most.
